Abstract
ABSTRACT The aim of this review was to estimate the prevalence of cardiometabolic disease indicators in people with psychotic disorders in secure settings. A PRISMA guided systematic search and appraisal was conducted for studies of metabolic disease indicators in samples of adult male and female inpatients in secure psychiatric hospitals and inmates in custodial centres with diagnoses of psychotic disorders. Seventeen studies were selected for review. An ability to validly summarise and compare prevalence data across studies were limited by the extent of methodological heterogeneity. The weighted pooled prevalence rates were determined to be: metabolic syndrome 23.5% (N = 1,390, 95% CI 21.3, 25.7), diabetes 11.2% (N = 2,582, 95% CI 9.9, 12.4), dyslipidaemia 29.2% (N = 1,135, 95% CI 26.6, 31.9), hypertension 25.0% (N = 857, 95% CI 22.1, 27.9), being overweight or obese 72.4% (N = 840, 95% CI 69.4, 75.5) and cardiovascular disease 15.6% (N = 1,047, 95% CI 13.4, 17.8). The prevalence of CMD indicators in people with psychotic disorders in secure settings were predominantly higher compared to the general population and either similar or lower compared to people with psychotic disorders in the community.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
